Regulation of DU145 prostate cancer cell growth by Scm-like with four mbt domains 2

Journal of Biosciences

Volumn 38, Issue 1, 2013, Pages 105-112

  Lee, Kwanghyun ^a   Na, Wonho ^a   Maeng, Je Heon ^a   Wu, Hongjin ^a   Ju, Bong Gun ^a  

^a Sogang University   (South Korea)

Author keywords

Cancer cell; histone methylation; HOXB13 gene expression; polycomb group; SFMBT2

Indexed keywords

HISTONE H3; HISTONE H4; ONCOPROTEIN; PROTEIN SFMBT2; UNCLASSIFIED DRUG;

CANCER; GENE EXPRESSION; METHYLATION; PROTEIN;

ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; BINDING SITE; CANCER CELL; CANCER GROWTH; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION REGULATION; GENE REPRESSION; GROWTH REGULATION; HISTONE METHYLATION; HOXB13 GENE; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; ONCOGENE; PROMOTER REGION; PROSTATE CANCER; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN DOMAIN; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

MAMMALIA;

EID: 84873717809     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-012-9283-6     Document Type: Article

References (28)

1. Begon DY, Delacroix L, Vernimmen D, Jackers P and Winkler R 2005 Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells. J. Biol. Chem. 280 24428-24434
2. Bonasio R, Lecona E and Reinberg D 2010 MBT domain proteins in development and disease. Semin. Cell Dev. Biol. 21 221-230
3. Cui H, Hu B, Li T, Ma J, Alam G, Gunning WT and Ding HF 2007 Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am. J. Pathol. 170 1370-1378
4. Donohoe ME, Zhang X, McGinnis L, Biggers J, Li E and Shi Y 1999 Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol. Cell. Biol. 19 7237-7244
5. Frankenberg S, Smith L, Greenfield A and Zernicka-Goetz M 2007 Novel gene expression patterns along the proximo-distal axis of the mouse embryo before gastrulation. BMC Dev. Biol. 7, 8
6. Grimm C, Matos R, Ly-Hartig N, Steuerwald U, Lindner D, Rybin V, Muller J and Muller CW 2009 Molecular recognition of histone lysine methylation by the Polycomb group repressor dSfmbt. EMBO J. 28 1965-1977
7. Gordon S, Akopyan G, Garban H and Bonavida B 2006 Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25 1125-1142
8. Harlow E and Lane D 1988 Using antibodies: a laboratory manual (New York: Cold Spring Harbor Laboratory Press) pp 55-137
9. Izzo A and Schneider R 2011 Chatting histone modifications in mammals. Brief Funct. Genomics 9 429-443
10. Jung C, Kim RS, Lee SJ, Wang C and Jeng MH 2004a HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4. Cancer Res. 64 3046-3051
11. Jung C, Kim RS, Zhang HJ, Lee SJ and Jeng MH 2004b HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling. Cancer Res. 64 9185-9192
12. Kirmizis A, Bartley SM, Kuzmichev A, Margueron R, Reinberg D, Green R and Farnham PJ 2004 Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev. 18 1592-1605
13. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA and Chinnaiyan AM 2003 EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. USA 100 11606-11611
14. Klymenko T, Papp B, Fischle W, Kocher T, Schelder M, Fritsch C, Wild B, Wilm M and Muller J 2006 APolycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activities. Genes Dev. 20 1110-1122
15. Kotake Y, Cao R, Viatour P, Sage J, Zhang Y and Xiong Y 2007 pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev. 21 49-54
16. Kuzmin A, Han Z, Golding MC, Mann MR, Latham KE and Varmuza S 2008 The PcG gene Sfmbt2 is paternally expressed in extraembryonic tissues. Gene Expr. Patterns 8 107-116
17. Lee JK, Lee DH, Sun EG, Bae JA, Lim SC, Min JJ, Sung MW and Kim KK 2011 Gene therapy for head and neck squamous cell carcinoma using KITENIN (KAI1 COOH-Terminal Interacting Tetraspanin)-antisense therapy. Yonsei Med. J. 52 463-468
18. Lukacs RU, Memarzadeh S, Wu H and Witte ON 2010 Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell 7 682-693
19. Maurer-Stroh S, Dickens NJ, Hughes-Davies L, Kouzarides T, Eisenhaber F and Ponting CP 2003 The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem. Sci. 28 69-74
20. Morey L and Helin K 2010 Polycomb group protein-mediated repression of transcription. Trends Biochem. Sci. 35 323-332
21. Raffo A, Lai JC, Stein CA, Miller P, Scaringe S, Khvorova A, and Benimetskaya L 2004 Antisense RNA down-regulation of bcl-2 expression in DU145 prostate cancer cells does not diminish the cytostatic effects of G3139 (Oblimersen). Clin. Cancer Res. 10 3195-3206
22. Ren G, Zhang G, Dong Z, Liu Z, Li L, Feng Y, Su D, Zhang Y, Huang B and Lu J 2009 Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers. Int. J. Biochem. Cell Biol. 41 1094-1101
23. Rosenfeld JA, Wang Z, Schones DE, Zhao K, DeSalle R and Zhang MQ 2009 Determination of enriched histone modifications in non-genic portions of the human genome. BMC Genomics 10 143
24. Seligson D, Horvath S, Huerta-Yepez S, Hanna S, Garban H, Roberts A, Shi T, Liu X, Chia D, Goodglick L and Bonavida B 2005 Expression of transcription factor Yin Yang 1 in prostate cancer. Int. J. Oncol. 27 131-141
25. Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P, Donohoe M, Luke MP, Calvo D and Grossman SR 2004 Yin Yang 1 is a negative regulator of p53. Cell 117 859-872
26. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA and Chinnaiyan AM 2002 The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419 624-629
27. Wang H, Wang L, Erdjument-Bromage H, Vidal M, Tempst P, Jones RS and Zhang Y 2004 Role of histone H2A ubiquitination in Polycomb silencing. Nature 431 873-878
28. Wu S, Trievel RC and Rice JC 2007 Human SFMBT is a transcriptional repressor protein that selectively binds the N-terminal tail of histone H3. FEBS Lett. 581 3289-3296